7.1 Kell, Kidd, Duffy & Lutheran

Kell, Kidd, Duffy & Lutheran

Quick Answer: The Kell, Kidd, Duffy, and Lutheran systems sit outside ABO and Rh but carry major day-to-day testing weight in the blood bank. Kell (K/k) antigens live on a disulfide-linked glycoprotein that DTT and ZZAP destroy, which is exactly why those reagents are used to strip antibody from red cells during warm-autoantibody workups. Kidd (Jka/Jkb) antibodies are notorious for delayed hemolytic transfusion reactions because titers fall below detectable thresholds between the antibody screen and the crossmatch. Duffy (Fya/Fyb) antigens are destroyed by ficin and papain, a key clue in enzyme-panel antibody identification. Lutheran (Lua/Lub) antibodies are usually weak, naturally occurring IgM that produce a distinctive mixed-field, loosely agglutinated pattern and rarely cause hemolysis.

The Kell System

The Kell blood group system is carried on the Kell glycoprotein, a type II membrane protein that is covalently linked by a single disulfide bond to the XK protein (Kx antigen). This disulfide linkage is the single most testable biochemical fact about Kell: reducing agents such as dithiothreitol (DTT) and the combined reagent ZZAP (DTT plus a proteolytic enzyme) cleave the bond, denature the Kell glycoprotein, and abolish Kell system antigen expression on treated red cells. Technologists exploit this in two settings: preparing autoantibody-free cells for phenotyping a patient with a warm autoantibody, since DTT strips bound IgG along with Kell antigens, and confirming that a suspected Kell antibody disappears against DTT-treated panel cells while non-Kell-system antibodies remain reactive. A rare recessive condition, McLeod phenotype, results from absent Kx expression; because Kx normally supports Kell antigen density, McLeod red cells show markedly depressed Kell antigens, acanthocytosis, and a shortened red cell lifespan, and the McLeod gene locus is adjacent to the gene responsible for chronic granulomatous disease, so the two conditions can co-segregate in the same family.

K (K1) is present in only about 9% of the Caucasian population, making it a low-prevalence antigen, while k (Cellano, K2) is present in more than 99.8% of people, a classic high-prevalence antigen. Despite its low frequency, K is the most immunogenic red cell antigen after D, so anti-K appears often relative to its rarity. Anti-K in pregnancy deserves special attention: unlike anti-D, which predominantly destroys mature circulating red cells, anti-K binds Kell glycoprotein expressed on early erythroid progenitor cells in fetal bone marrow and suppresses erythropoiesis directly. Because the fetus becomes anemic without a large hemolytic component, amniotic fluid delta OD450 (bilirubin) measurements can significantly underestimate severity, and middle cerebral artery (MCA) Doppler peak systolic velocity is the preferred non-invasive monitoring tool once maternal anti-K is identified.

The Kidd System

Jka and Jkb are antithetical alleles encoded on the gene for a urea transporter protein (UT-B, also called HUT11 or JK glycoprotein), and this transporter function has a memorable phenotypic consequence: rare Jk(a-b-) red cells resist lysis in 2M urea because they lack a functional urea channel, a property once used as a rapid screening test for the null phenotype. Clinically, Kidd antibodies have an outsized reputation relative to their modest immunogenicity because of their behavior, not their frequency. Anti-Jka and anti-Jkb are complement-binding IgG antibodies that decline rapidly in titer, sometimes becoming undetectable by routine antibody screening within weeks to months of an immunizing event. When a previously sensitized patient is re-exposed, an anamnestic (secondary) response can produce a rapid, high-titer antibody that was invisible on the pretransfusion screen, causing a delayed hemolytic transfusion reaction days after an apparently compatible transfusion. Kidd antigen expression is enhanced by proteolytic enzyme treatment (ficin or papain), so enzyme panels and polyethylene glycol (PEG)-enhanced indirect antiglobulin testing improve detection sensitivity for weak or evanescent Kidd antibodies. Kidd antibodies also show pronounced dosage: they react more strongly with red cells homozygous for the corresponding antigen (Jk(a+b-)) than with heterozygous cells (Jk(a+b+)), so a weak antibody may be missed entirely if only heterozygous panel cells are tested.

The Duffy System

Fya and Fyb reside on the Duffy antigen receptor for chemokines (DARC, also known as ACKR1), which also serves as the entry receptor Plasmodium vivax uses to invade red cells. The Fy(a-b-) phenotype, caused by a promoter mutation that silences erythroid expression of the gene, is common in individuals of West African ancestry and confers resistance to P. vivax malaria, making it one of the clearest examples of a blood group polymorphism shaped by infectious disease selection pressure. From a testing standpoint, Duffy antigens are markedly sensitive to proteolytic enzymes: ficin or papain treatment destroys Fya and Fyb reactivity. This is diagnostically useful — if an antibody reacts with untreated panel cells but the reactivity disappears after enzyme treatment, Duffy specificity becomes a leading candidate, helping to resolve mixtures of antibodies in a single serum sample.

The Lutheran System

Lua and Lub are located on a glycoprotein belonging to the immunoglobulin superfamily and are expressed relatively weakly on the red cell membrane. Anti-Lua is frequently naturally occurring, IgM, reacts best at room temperature, and characteristically produces loose, refractile, mixed-field agglutination that can be mistaken for a technical artifact rather than true agglutination. Anti-Lub is less common, usually IgG, but both antibodies are only rarely implicated in significant hemolytic transfusion reactions or hemolytic disease of the fetus and newborn. The rare Lu(a-b-) null phenotype can arise two ways: a recessive form from homozygosity for silent Lutheran alleles, and a more commonly encountered dominant form caused by an inhibitor gene, In(Lu), which suppresses not only Lutheran antigens but also depresses expression of P1, i, and several other unrelated antigens on the same red cells — a useful reminder that antigen suppression is not always confined to a single blood group system.

Quick Reference